FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to compounds of formula (I) and to their pharmaceutically acceptable salts and to use of such compounds as medicinal agents.
EFFECT: obtaining novel compounds which are suitable as CXCR3 receptor modulators.
14 cl, 2 tbl, 21 ex
Title | Year | Author | Number |
---|---|---|---|
HETEROCYCLIC DERIVATIVES OF AZOLONES EFFECTING AGAINST HELICOBACTER, PHARMACEUTICAL COMPOSITION AND METHOD OF THEIR SYNTHESIS | 1995 |
|
RU2152940C1 |
HETEROBICYCLO-SUBSTITUTED-[1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES | 2013 |
|
RU2671628C2 |
TETRAHYDROTRIAZOLOPYRIMIDINE DERIVATIVES AS INHIBITORS OF HUMAN NEUTROPHIL ELASTASE | 2012 |
|
RU2622643C2 |
AZABICYCLO{3,1,0}HEXANE DERIVATIVES USED AS DOPAMINE RECEPTOR D3 MODULATORS | 2005 |
|
RU2434011C2 |
TRIAZOLO-PYRIMIDINE COMPOUNDS AND THEIR USE | 2019 |
|
RU2802866C2 |
NEW PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AND APPLICATION THEREOF | 2014 |
|
RU2621709C2 |
PYRIMIDINE DERIVATIVES AND USING THEM IN TREATING RESPIRATORY DISEASES, SUCH AS COPD | 2011 |
|
RU2581839C2 |
PYRIMIDINE DERIVATIVES AND USE THEREOF IN TREATING RESPIRATORY DISEASES, SUCH AS COPD | 2011 |
|
RU2604719C2 |
AMINOTETRAHYDROPYRANES AS DIPEPTIDYLPEPTIDASE-IV INHIBITORS FOR TREATING OR PREVENTING DIABETES | 2010 |
|
RU2550508C2 |
1-[M-CARBOXAMIDO(HETERO)ARYL-METHYL]-HETEROCYCLYL-CARBOXAMIDE DERIVATIVES | 2013 |
|
RU2644761C2 |
Authors
Dates
2019-11-15—Published
2016-01-14—Filed